Tembhare, P. R., Sriram, H., Khanka, T., Chatterjee, G., Panda, D., Ghogale, S., . . . Subramanian, P. G. Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: An implication for anti-CD38 immunotherapy. BMJ Publishing Group.
Chicago Style (17th ed.) CitationTembhare, Prashant Ramesh, et al. Flow Cytometric Evaluation of CD38 Expression Levels in the Newly Diagnosed T-cell Acute Lymphoblastic Leukemia and the Effect of Chemotherapy on Its Expression in Measurable Residual Disease, Refractory Disease and Relapsed Disease: An Implication for Anti-CD38 Immunotherapy. BMJ Publishing Group.
MLA (9th ed.) CitationTembhare, Prashant Ramesh, et al. Flow Cytometric Evaluation of CD38 Expression Levels in the Newly Diagnosed T-cell Acute Lymphoblastic Leukemia and the Effect of Chemotherapy on Its Expression in Measurable Residual Disease, Refractory Disease and Relapsed Disease: An Implication for Anti-CD38 Immunotherapy. BMJ Publishing Group.